| 1 | Oxycodone/naloxone prolonged release t | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 2261件: 226 💬 | 
| 2 | Oxycodone/naloxone prolonged release tablets | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 3 | Oxycodone/naloxone prolonged release tablets 10 mg /5 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 4 | Oxycodone/naloxone prolonged release tablets 10/5 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 2261件: 226 💬 | 
| 5 | Oxycodone/naloxone prolonged release tablets 20 mg /10 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 6 | Oxycodone/naloxone prolonged release tablets 20/10 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 2261件: 226 💬 | 
| 7 | Oxycodone/naloxone prolonged release tablets 5 mg /2.5 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 0061件:  6  💬 | 
| 8 | Oxycodone/naloxone prolonged release tablets 5/2.5 mg | Naloxone | 5件: D01340D01340, D03783D03783, D05312D05312, D05462D05462, D08249D08249 💬 | OPRD13件: OPRD1, OPRK1, OPRM1 💬 | Estrogen signaling pathway5件: Estrogen signaling pathway, Morphine addiction, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway | 2261件: 226 💬 |